ReviewClinical parkinsonism & related disorders2026
Glucagon-like peptide-1 receptor agonists in movement disorders: From Parkinson's disease to the broader spectrum - Mechanisms, evidence, and future directions.
Ahmed Dahshan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.